Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Dwarakanath

Showing results (11-20 of 171) with videos related to

Pageof 18
Sort By:
American Journal of Obstetrics and Gynecology|January 1, 1996
Primary abdominal pregnancy: disregarding clinical features leads to misdiagnosisP S Persad, L S Dwarakanath
Journal of Cancer Research and Therapeutics|February 13, 2014
Differential cytotoxicity of the glycolytic inhibitor 2-deoxy-D-glucose in isogenic cell lines varying in their p53 statusArchana Vibhuti, Kambadur Muralidhar, Bilikere S Dwarakanath
Cancer Biology & Therapy|February 16, 2005
The glycolytic inhibitor 2-deoxy-D-glucose enhances the efficacy of etoposide in ehrlich ascites tumor-bearing miceSeema Gupta, Rohit Mathur, B S Dwarakanath
Indian Journal of Experimental Biology|February 25, 2000
Optimization of tumour radiotherapy: Part V--Radiosensitization by 2-deoxy-D-glucose and DNA ligand Hoechst-33342 in a murine tumourB S Dwarakanath, S Singh, V Jain
Journal of Vector Borne Diseases|January 28, 2005
Spontaneous subdural empyema in falciparum malaria: a case studyS Dwarakanath, A Suri, A K Mahapatra
Indian Journal of Experimental Biology|September 2, 2004
Inhibitors of topoisomerases as anticancer drugs: problems and prospectsB S Dwarakanath, Divya Khaitan, Rohit Mathur
Journal of Biomolecular Structure & Dynamics|August 1, 1997
Dynamics simulation of the interaction between the novel intercalator diethidium cation and B-form DNAR R Monaco, W Polkosnik, S Dwarakanath
Cancer Reports (Hoboken, N.J.)|July 31, 2020
Targeting regulatory T cells for improving cancer therapy: Challenges and prospectsBilikere S Dwarakanath, Abdullah Farooque, Seema Gupta
Cancer Biology & Therapy|July 16, 2004
2-deoxy-D-glucose enhances the cytotoxicity of topoisomerase inhibitors in human tumor cell linesB S Dwarakanath, Divya Khaitan, T Ravindranath
Technology in Cancer Research & Treatment|November 25, 2004
Radiosensitization of murine Ehrlich ascites tumor by a combination of 2-deoxy-D-glucose and 6-aminonicotinamideR Varshney, S Gupta, B S Dwarakanath
Pageof 18

Showing results (11-20 of 171) with videos related to

Sort By:
Pageof 18
American Journal of Obstetrics and Gynecology|January 1, 1996
Primary abdominal pregnancy: disregarding clinical features leads to misdiagnosisP S Persad, L S Dwarakanath
Journal of Cancer Research and Therapeutics|February 13, 2014
Differential cytotoxicity of the glycolytic inhibitor 2-deoxy-D-glucose in isogenic cell lines varying in their p53 statusArchana Vibhuti, Kambadur Muralidhar, Bilikere S Dwarakanath
Cancer Biology & Therapy|February 16, 2005
The glycolytic inhibitor 2-deoxy-D-glucose enhances the efficacy of etoposide in ehrlich ascites tumor-bearing miceSeema Gupta, Rohit Mathur, B S Dwarakanath
Indian Journal of Experimental Biology|February 25, 2000
Optimization of tumour radiotherapy: Part V--Radiosensitization by 2-deoxy-D-glucose and DNA ligand Hoechst-33342 in a murine tumourB S Dwarakanath, S Singh, V Jain
Journal of Vector Borne Diseases|January 28, 2005
Spontaneous subdural empyema in falciparum malaria: a case studyS Dwarakanath, A Suri, A K Mahapatra
Indian Journal of Experimental Biology|September 2, 2004
Inhibitors of topoisomerases as anticancer drugs: problems and prospectsB S Dwarakanath, Divya Khaitan, Rohit Mathur
Journal of Biomolecular Structure & Dynamics|August 1, 1997
Dynamics simulation of the interaction between the novel intercalator diethidium cation and B-form DNAR R Monaco, W Polkosnik, S Dwarakanath
Cancer Reports (Hoboken, N.J.)|July 31, 2020
Targeting regulatory T cells for improving cancer therapy: Challenges and prospectsBilikere S Dwarakanath, Abdullah Farooque, Seema Gupta
Cancer Biology & Therapy|July 16, 2004
2-deoxy-D-glucose enhances the cytotoxicity of topoisomerase inhibitors in human tumor cell linesB S Dwarakanath, Divya Khaitan, T Ravindranath
Technology in Cancer Research & Treatment|November 25, 2004
Radiosensitization of murine Ehrlich ascites tumor by a combination of 2-deoxy-D-glucose and 6-aminonicotinamideR Varshney, S Gupta, B S Dwarakanath
Pageof 18